Impaired hepatic removal of interleukin-6 in patients with liver cirrhosis

Wiest, Reiner; Weigert, Johanna; Wanninger, Josef; Neumeier, Markus; Bauer, Sabrina; Schmidhofer, Sandra; Farkas, Stefan; Scherer, Marcus N; Schäffler, Andreas; Schölmerich, Jürgen; Buechler, Christa (2011). Impaired hepatic removal of interleukin-6 in patients with liver cirrhosis. Cytokine, 53(2), pp. 178-83. Philadelphia, Pa.: Saunders 10.1016/j.cyto.2010.06.013

Full text not available from this repository. (Request a copy)

Systemic concentrations of interleukin-6 (IL-6) are elevated in patients with liver cirrhosis, and impaired hepatic uptake of IL-6 was suggested to contribute to higher levels in these patients. To test this hypothesis IL-6 was measured in portal venous serum (PVS), hepatic venous serum (HVS) and systemic venous serum (SVS) of 41 patients with liver cirrhosis and four patients with normal liver function. IL-6 was higher in PVS than HVS of all blood donors and about 43% of portal vein derived IL-6 was extracted by the healthy liver, and 6.3% by the cirrhotic liver demonstrating markedly impaired removal of IL-6 by the latter. Whereas in patients with CHILD-PUGH stage A IL-6 in HVS was almost 25% lower than in PVS, in patients with CHILD-PUGH stage C IL-6 was similarly abundant in the two blood compartments. Ascites is a common complication in cirrhotic patients and was associated with higher IL-6 levels in all blood compartments without significant differences in hepatic excretion. Hepatic venous pressure gradient did not correlate with the degree of hepatic IL-6 removal excluding hepatic shunting as the principal cause of impaired IL-6 uptake. Furthermore, patients with alcoholic liver cirrhosis had higher IL-6 in all blood compartments than patients with cryptogenic liver cirrhosis. Aetiology of liver cirrhosis did not affect hepatic removal rate indicating higher IL-6 synthesis in patients with alcoholic liver cirrhosis. In summary, the current data provide evidence that impaired hepatic removal of IL-6 is explained by hepatic shunting and liver dysfunction in patients with liver cirrhosis partly explaining higher systemic levels.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine > Gastroenterology

UniBE Contributor:

Wiest, Reiner

ISSN:

1043-4666

Publisher:

Saunders

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:23

Last Modified:

17 Mar 2015 21:01

Publisher DOI:

10.1016/j.cyto.2010.06.013

PubMed ID:

20637651

Web of Science ID:

000287272700009

URI:

https://boris.unibe.ch/id/eprint/7774 (FactScience: 213100)

Actions (login required)

Edit item Edit item
Provide Feedback